Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-02-25
    E.g., 2018-02-25

Articles

49993 items
12:00 AM, Mar 13, 2000  |  BC Extra | Company News

Bristol-Myers deal with Schering-Plough

The companies will co-promote BMY's Tequin gatifloxacin broad-spectrum antibiotic to treat respiratory tract and other infections in the U.S. The FDA approved the product in December....
12:00 AM, Mar 13, 2000  |  BC Extra | Company News

GeneTrace acquires Strata Biosciences

GeneTrace Systems (Alameda, Calif.) acquired Strata Biosciences (Alameda, Calif.), which uses high throughput gene knockout technologies and cell-based assays for gene discovery, drug target identification and validation. GeneTrace will add these technologies to its Systems...
12:00 AM, Mar 13, 2000  |  BC Extra | Clinical News

Idun publishes Parkinson's target

Idun and colleagues published in the Proceedings of the National Academy of Sciences that expression of the apoptosis-promoting enzyme caspase-3 was associated with increased neuronal cell death in patients with PD. They suggested that...
12:00 AM, Mar 13, 2000  |  BC Extra | Financial News

Geron files for follow-on

GERN filed to sell 3 million shares, with a 450,000-share overallotment option. The follow-on will be underwritten by J.P. Morgan; Robertson Stephens; and Salomon Smith Barney. GERN, which is focused on cancer and regenerative medicine,...
12:00 AM, Mar 13, 2000  |  BC Extra | Financial News

Biopure raises $87.5 million

The oxygen therapeutics company priced 2.5 million common shares at $35 each through a syndicate including J.P. Morgan; Salomon Smith Barney; Robert W. Baird; and Adams Harkness & Hill, which have a 375,000-share overallotment option....
12:00 AM, Mar 13, 2000  |  BC Extra | Financial News

Celgene 3-for-1 split

CELG's board declared a 3-for-1 split of the company's 21.4 million shares outstanding for shareholders of record as of April 11. The split is contingent on an April 10 shareholder vote to increase the number...
12:00 AM, Mar 13, 2000  |  BC Extra | Financial News

GelTex raises $35 million

GELX sold 1.75 million shares at $20 in a private placement to a group of institutional investors. GELX will use a portion of the funds to increase manufacturing capacity for its CholestaGel colesevelam to treat...
12:00 AM, Mar 13, 2000  |  BC Extra | Financial News

Serologicals postpones earnings release

SERO, a supplier of biological materials and services, postponed the release of its fourth quarter and fiscal year earnings, which were expected next week. SERO was down $2.125 (24 percent) to $6.875 on Monday....
12:00 AM, Mar 13, 2000  |  BC Extra | Financial News

Deutsche Banc begins Diversa coverage

Deutsche Banc Alex. Brown analyst Dennis Harp began coverage with a "buy" and a $157 price target. He said that the company's combination of biodiversity and directed evolution make it a compelling genomics play. DVSA...
12:00 AM, Mar 13, 2000  |  BC Extra | Financial News

Avax raises $25.1 million

AVXT sold 2.26 million shares at $11.125 per share, a portion of which will be used to fund development of its M-Vax and O-Vax autologous haptenized tumor cell vaccines. M-Vax is in Phase III testing...

Pages